6th IFSO Global Registry Report (2021)
-
Code:978-1-9160207-8-8
This is the Sixth Report of the International Federation for the Surgery of Obesity and Metabolic Disorders ( IFSO ) Global Registry, a collaboration with Dendrite Clinical Systems.
This year’s report contains information from 507,298 operations from 50 contributor countries. Data for this report has been submitted by national registries, regional registries and single-centres. When reviewing the graphs you will note that not every contributor country appears in every graph. This is because sometimes the data are unavailable or because there are fewer than 100 operation records submitted from that country, making the data prone to bias.
Throughout this report, we have sought to highlight data from national / regional registries that we believe capture at least 80% of the patients undergoing metabolic / bariatric surgery in their country. We have chosen to highlight their outcomes as these data are likely to be less prone to bias, and more likely to reflect the activity in their country than national registries with a lower rate of data acquisition and single centres.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


